drugset / Trial / NCT07846722

Esmolol Versus Dexmedetomidine for Opioid-sparing in Laparoscopic Gynecological Surgery

NCT07846722 ↗

Recruiting 90 enrolled Vasiliki Samartzi
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The aim of this study is to investigate and compare the effects of a continuous infusion of low-dose esmolol and dexmedetomidine versus placebo on intraoperative and postoperative opioid consumption and analgesic efficacy in patients undergoing laparoscopic hysterectomy.

Timeline

Start
2026-07-15
Primary completion
2026-12-01
Completion
2027-02-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator Dexmedetomidine Other / unclassified 0.501 ug/kg —
Comparator Esmolol Other / unclassified 3 mg/kg —

Indications

No indication recorded.